- 2015 American Transplant Congress - Marked Suppression of Posttransplant Alloantibody Production and Primed B cell Function In Vivo by mTOR Inhibition Compared to Calcineurin Inhibition- Department of Surgery, CTC, The Ohio State University, Columbus, OH. mTOR inhibitors [mTORi; Rapamycin, (Rapa)] and calcineurin inhibitors [CNi; Tacrolimus (Tac)] are immunosuppressives commonly used to suppress rejection of transplants. Despite widespread use following transplantation…
- 2015 American Transplant Congress - Trajectory of Measured GFR Decades After Kidney Donation: Hyperfiltration Never Seems to End!While the effect of uninephrectomy on loss of GFR is a cardinal issue for potential kidney donors, current information relies on surrogates of unknown validity,…
- 2015 American Transplant Congress - Alloantibody-Dependent Macrophage-Mediated Hepatocellular Damage Is Dependent on FcγRI, FcγRIII, and Reactive Oxygen Species- Dept of Surgery, CTC, The Ohio State University Wexner Medical Center, Columbus, OH. Alloantibodies (alloAb) play a critical role in rejection after transplantation. Despite this, the cellular mechanisms contributing to alloAb-mediated allograft damage are not well understood. Using…
- 2015 American Transplant Congress - Longitudinal Follow-Up of Cardiovascular Comorbidity in Pediatric Renal Transplant Recipients – Results from the 4C-T StudyPurpose: Children with chronic kidney disease (CKD) carry an increased cardiovascular risk. Cardiovascular death is the second leading cause of death in children after renal…
- 2015 American Transplant Congress - Dramatic Primary Expansion of Indirect CD4 T Cells to Allogeneic APCs In VivoAn ongoing question regarding the primary allograft response is the relative contribution of the 'direct' (donor MHC-restricted) versus 'indirect' (host MHC-restricted) pathways of T cell…
- 2015 American Transplant Congress - Pretransplant Antibodies Against Angiotensin II Type 1 Receptor in Renal Transplantation: Preliminary Data from the KNOW-KT StudyBackgroundThe antibodies (Abs) against angiotensin II type 1 receptor (AT1R) have been suggested as a risk factor for graft failure and acute rejection. However, incidence…
- 2015 American Transplant Congress - Toxoplasmosis Post-Kidney Or Liver Transplantation: A Serie of CasesToxoplasmosis is a rare complication post-SOT, occurring mostly in D+/R- mismatch. However, in highly endemic areas, the disease occurs predominantly in R+ under post-tx immunosuppressive…
- 2015 American Transplant Congress - Quantifying the Survival Benefit of HLA-Incompatible Kidney Transplantation: A Multi-Center Study- Surgery, Hopkins, Baltimore, MD. A single center study has demonstrated a two-fold survival benefit of incompatible live donor kidney transplant (ILDKT) compared to remaining on dialysis. We sought to…
- 2015 American Transplant Congress - Short- and Long-Term Outcomes of Mycophenolate Versus Azathioprine in a Large Cohort of Renal Transplant Recipients- 1Barnes-Jewish Hospital, St. Louis; 2Washington University School of Medicine, St. Louis. Purpose: Early studies comparing mycophenolate mofetil (MMF) to azathioprine (AZA) post-renal transplantation demonstrated superiority of MMF over AZA for the prevention of acute rejection (AR).…
- 2015 American Transplant Congress - Post-Liver Transplant Metabolic Syndrome Increases the Risk of Recurrent Fibrosis in Patients With Hepatitis C- Department of Medicine, Columbia University, New York, NY. Introduction: Post-liver transplant (LT) metabolic syndrome (MS) is common and may impact fibrosis progression in LT recipients with hepatitis C virus (HCV). Methods: All adults…
- « Previous Page
- 1
- …
- 127
- 128
- 129
- 130
- 131
- …
- 170
- Next Page »
